v3.26.3
Other Consolidated Financial Statement Detail (Tables)
 9 Months Ended
Sep. 30, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Other income (expense), net
Components of other (income) expense, net, are summarized as follows:
For the Three Months Ended September 30,For the Nine Months Ended September 30,
(In millions)2026202520262025
Interest income$(9.3)$(31.6)$(72.5)$(87.8)
Interest expense87.5 67.4 237.4 200.0 
(Gains) losses on investments, net33.3 3.8 (30.6)34.1 
Litigation related expense30.8 0.8 35.1 9.0 
Foreign exchange (gains) losses, net6.3 10.3 19.3 16.9 
Other, net(11.2)(16.6)(13.1)(21.0)
Total other (income) expense, net$137.4 $34.1 $175.6 $151.2 
Gain (loss) on investments in equity securities
The following table summarizes our (gains) losses on investments, net that relate to our equity securities held during the following periods:
For the Three Months Ended September 30,For the Nine Months Ended September 30,
(In millions)2026202520262025
Net (gains) losses recognized on equity securities$33.3 $3.8 $(31.8)$34.1 
Less: Net (gains) losses realized on equity securities8.2 7.0 5.0 1.6 
Net unrealized (gains) losses recognized on equity securities$25.1 $(3.2)$(36.8)$32.5 
Accrued expenses and other
Accrued expense and other consists of the following:
(In millions)As of September 30, 2026As of December 31, 2025
Revenue-related reserves for discounts and allowances$1,019.5 $1,000.4 
Employee compensation and benefits451.2 375.8 
Collaboration expense234.3 280.0 
Royalties and licensing fees348.4 302.4 
Other960.2 844.0 
Total accrued expense and other$3,013.6 $2,802.6 
For additional information on our acquisition of Apellis, please read Note 2, Acquisitions, to these condensed consolidated financial statements.